Previous close | 2.1000 |
Open | 2.2200 |
Bid | 2.0700 x 0 |
Ask | 2.2200 x 0 |
Day's range | 2.1000 - 2.2200 |
52-week range | 1.4450 - 2.7200 |
Volume | |
Avg. volume | 27,839 |
Market cap | 179.392M |
Beta (5Y monthly) | 1.47 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings date | 27 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
EMVision Medical Devices ( ASX:EMV ) Full Year 2024 Results Key Financial Results Revenue: AU$11.6m (up 66% from FY...
SYDNEY, July 23, 2024--EMVision (ASX: EMV), an Australian medical device company focused on the development and commercialisation of innovative portable brain scanning technology, has today unveiled its First Responder Proof of Concept device, designed for deployment via road and air ambulances.
It hasn't been the best quarter for EMVision Medical Devices Ltd ( ASX:EMV ) shareholders, since the share price has...